1. The hyperbolic law—a 25-year perspective

   • M. Stumvoll
   • P. A. Tataranni
   • C. Bogardus

   Commentary 22 January 2005 Pages: 207 - 209

   

2. Symptoms, signs and complications in newly diagnosed type 2 diabetic patients, and their relationship to glycaemia, blood pressure and weight

   • T. Drivsholm
   • N. de Fine Olivarius
   • V. Siersma

   Short communication 14 January 2005 Pages: 210 - 214

3. Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study

   • P. Mackin
   • H. M. Watkinson
   • A. H. Young

   Article 02 February 2005 Pages: 215 - 221

4. Use of a reference four-component model to define the effects of insulin treatment on body composition in type 2 diabetes: the ‘Darwin study’

   • I. C. Packianathan
   • N. J. Fuller
   • N. Finer

   Article 02 February 2005 Pages: 222 - 229

5. Relationship between HbA₁c and mortality in a Japanese population

   • S. Nakanishi
   • M. Yamada
   • G. Suzuki

   Article 14 January 2005 Pages: 230 - 234

6. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population

   • The MONICA/KORA Augsburg Cohort Study
   • C. Meisinger
   • H. Loewel

   Article 11 January 2005 Pages: 235 - 241

7. Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer

   • B. Liljeström
   • K. Aktan-Collan
   • T. Tuomi

   Article 20 January 2005 Pages: 242 - 250

   

8. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes

   • Y. H. Hamid
   • C. S. Rose
   • O. Pedersen

   Article 11 January 2005 Pages: 251 - 260

9. mt-Nd2 Allele of the ALR/Lt mouse confers resistance against both chemically induced and autoimmune diabetes

   • C. E. Mathews
   • E. H. Leiter
   • N. Fischel-Ghodsian

   Article 04 February 2005 Pages: 261 - 267

   

10. A functional CD40 receptor is expressed in pancreatic beta cells

    • D. Klein
    • F. Barbé-Tuana
    • R. L. Pastori

    Article 03 February 2005 Pages: 268 - 276

    

11. Fibroblast growth factors 7 and 10 are expressed in the human embryonic pancreatic mesenchyme and promote the proliferation of embryonic pancreatic epithelial cells

    • F. Ye
    • B. Duvillié
    • R. Scharfmann

    Short Communication 03 February 2005 Pages: 277 - 281

    

12. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients

    • M. Anello
    • R. Lupi
    • P. Marchetti

    Article 15 January 2005 Pages: 282 - 289

    

13. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes

    • A. Imagawa
    • T. Hanafusa
    • P. Juto

    Short communication 15 January 2005 Pages: 290 - 293

    

14. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus

    • A. Imagawa
    • T. Hanafusa
    • H. Makino

    Article 02 February 2005 Pages: 294 - 300

15. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study

    • M. B. Snijder
    • M. Visser
    • for the Health ABC Study

    Article 20 January 2005 Pages: 301 - 308

    

16. The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes

    • S. M. Pöykkö
    • O. Ukkola
    • Y. A. Kesäniemi

    Article 02 February 2005 Pages: 309 - 316

    

17. Renal clearance of glycolaldehyde- and methylglyoxal-modified proteins in mice is mediated by mesangial cells through a class A scavenger receptor (SR-A)

    • K. Nakajou
    • S. Horiuchi
    • M. Otagiri

    Article 15 January 2005 Pages: 317 - 327

    

18. Dexamethasone impairs muscle energetics, studied by ³¹P NMR, in rats

    • J.-F. Dumas
    • G. Bielicki
    • P. Ritz

    Article 08 January 2005 Pages: 328 - 335

    

19. Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes

    • T. Sasaoka
    • K. Fukui
    • M. Kobayashi

    Article 15 January 2005 Pages: 336 - 344

    

20. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA₁c

    • J. A. McClung
    • N. Naseer
    • A. Kappas

    Article 20 January 2005 Pages: 345 - 350

    

21. Glutamate uptake in retinal glial cells during diabetes

    • M. M. Ward
    • A. I. Jobling
    • E. L. Fletcher

    Article 02 February 2005 Pages: 351 - 360

    

22. Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells

    • B. E. Brown
    • R. T. Dean
    • M. J. Davies

    Article 20 January 2005 Pages: 361 - 369

    

23. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study

    • M. T. Schram
    • N. Chaturvedi
    • EURODIAB Prospective Complications Study Group

    Article 04 February 2005 Pages: 370 - 378

    

24. Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes

    • P. D. Reaven
    • J. Sacks
    • Investigators for the VADT

    Article 02 February 2005 Pages: 379 - 385

    

25. Orosomucoid in urine is a powerful predictor of cardiovascular mortality in normoalbuminuric patients with type 2 diabetes at five years of follow-up

    • M. S. Christiansen
    • E. Hommel
    • B. Feldt-Rasmussen

    Article 11 January 2005 Pages: 386 - 393

    

26. Determinants of subclinical diabetic heart disease

    • Z. Y. Fang
    • R. Schull-Meade
    • T. H. Marwick

    Article 08 January 2005 Pages: 394 - 402

    

27. To the Editor

    • T. D. R. Hockaday

    Letters 03 February 2005 Pages: 403 - 404

    

28. EASD News Section February 2005

    EASD 04 March 2005 Pages: R21 - R26